Development and validation of a hypoxia-associated signature for lung adenocarcinoma.

Sci Rep · 2022 · PMC8789914 · PMID 35079065

Europe PMC DOI

hedged sentence

0.0950

closest p · 1.9× alpha

0.0950

boldest claim

The sentences

showed a trendp = 0.095so close (0.05 < p ≤ 0.1)

7 D), and showed a trend towards prognostic significance in GSE31210 (HR 1.92, 95% CI 0.88–4.21, p = 0.095) and GSE42127 (HR 2.00, 95% CI 0.98–4.01, p = 0.051) (Supplementary Fig. 7 F,G).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.